Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Assets (2016 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Return on Assets for 15 consecutive years, with 0.4% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 38.0% to 0.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.4% through Dec 2025, down 38.0% year-over-year, with the annual reading at 0.39% for FY2025, 36.0% down from the prior year.
  • Return on Assets hit 0.4% in Q4 2025 for Vanda Pharmaceuticals, down from 0.14% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q3 2021 to a low of 0.4% in Q4 2025.
  • Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.01% in 2022.
  • Biggest five-year swings in Return on Assets: rose 2bps in 2021 and later plummeted -38bps in 2025.
  • Year by year, Return on Assets stood at 0.06% in 2021, then plummeted by -82bps to 0.01% in 2022, then crashed by -62bps to 0.0% in 2023, then crashed by -860bps to 0.03% in 2024, then plummeted by -1292bps to 0.4% in 2025.
  • Business Quant data shows Return on Assets for VNDA at 0.4% in Q4 2025, 0.14% in Q3 2025, and 0.11% in Q2 2025.